U.S. ICD-10-CM · FY 2027

E79 ICD-10-CM Code: Disorders of purine and pyrimidine metabolism

A clear reference for the official code description, hierarchy, and related coding information from the FY 2027 U.S. release.

Code definition

Official description

E79

Disorders of purine and pyrimidine metabolism

ICD-10-CM diagnosis code · United States clinical modification

Classification

Where E79 sits

  1. 1

    Chapter 4

    Endocrine, nutritional and metabolic diseases (E00-E89)

  2. 2

    Section

    Metabolic disorders (E70-E88)

  3. 3

    Category E79

    Disorders of purine and pyrimidine metabolism

  4. 4

    Code E79

    Disorders of purine and pyrimidine metabolism

More specific choices

Codes under E79

E79 is a non-billable category. Choose the child code that best matches the documented diagnosis.

E79.0

Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

E79.1

Lesch-Nyhan syndrome

E79.2

Myoadenylate deaminase deficiency

E79.8

Other disorders of purine and pyrimidine metabolism

E79.9

Disorder of purine and pyrimidine metabolism, unspecified

Documentation details

Notes for this code

Inclusion terms

No inclusion terms are listed for E79.

Code first

No “code first” instruction is listed for E79.

Use additional code

No “use additional code” instruction is listed for E79.

Excludes1

Conditions that should not be reported together with this code.

  • Ataxia-telangiectasia (Q87.19)
  • Bloom's syndrome (Q82.8)
  • Cockayne's syndrome (Q87.19)
  • calculus of kidney (N20.0)
  • combined immunodeficiency disorders (D81.-)
  • Fanconi's anemia (D61.09)
  • gout (M1A.-, M10.-)
  • orotaciduric anemia (D53.0)
  • progeria (E34.8)
  • Werner's syndrome (E34.8)
  • xeroderma pigmentosum (Q82.1)

Excludes2

Conditions not included here that may be reported separately when present.

No Excludes2 note is listed for E79.

Transparency

Source and release

Data release

U.S. ICD-10-CM · FY 2027

Effective date

Oct 1, 2026

Publisher

Vero Scribe Inc.

This reference is generated from Vero’s ICD-10-CM description, hierarchy, and code-note dataset. The visible content and structured data share that source.

Review the CDC/NCHS ICD-10-CM source

Code-specific guidance

Frequently asked questions

What does ICD-10-CM code E79 mean?

E79 is the FY 2027 U.S. ICD-10-CM code for “Disorders of purine and pyrimidine metabolism.”

Is E79 a billable or specific ICD-10-CM code?

No. E79 has more specific child codes in the FY 2027 reference data. Select the code that matches the documentation and confirm the active code set and payer requirements.

Where is E79 located in ICD-10-CM?

E79 is listed in Chapter 4, Endocrine, nutritional and metabolic diseases (E00-E89), within Metabolic disorders (E70-E88) (E70–E88), under category E79, Disorders of purine and pyrimidine metabolism.

What coding notes are listed for E79?

No inclusion terms are listed for E79 in this reference record. No code-first instruction is listed. Excludes1 notes: Ataxia-telangiectasia (Q87.19); Bloom's syndrome (Q82.8); Cockayne's syndrome (Q87.19); calculus of kidney (N20.0); combined immunodeficiency disorders (D81.-); Fanconi's anemia (D61.09); gout (M1A.-, M10.-); orotaciduric anemia (D53.0); progeria (E34.8); Werner's syndrome (E34.8); xeroderma pigmentosum (Q82.1). No Excludes2 note is listed.

Ready to transform your clinical documentation?

Join Vero and see how effortless documentation can be.

Try for free

  • No credit card required

  • Cancel anytime